1,037
Participants
Start Date
July 31, 2013
Primary Completion Date
April 30, 2018
Study Completion Date
October 31, 2018
high dose indomethacin
patients randomized to this intervention receive 200mg indomethacin
standard dose indomethacin
patients randomized to this intervention receive 100mg indomethacin
Medical University of South Carolina, Charleston
Indiana University Health, Indianapolis
University of Michigan Medical Center, Ann Arbor
Aurora St. Lukes' Medical Center, Milwaukee
Methodist Dallas Medical Center, Dallas
Beth Israel Deaconess Medical Center, Boston
American College of Gastroenterology
OTHER
University of Michigan
OTHER
University of Texas
OTHER
Wake Forest University Health Sciences
OTHER
Medical University of South Carolina
OTHER
Beth Israel Deaconess Medical Center
OTHER
Indiana University
OTHER